Research

NurOwn AdComm Comments due 9/20!

December 19, 2022 Comments Off on NurOwn AdComm Comments due 9/20!

The FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee meets on Sept. 27 in open session to discuss and make recommendations on a biologics license application from BrainStorm Therapeutics, Inc.…